sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com
Patient Information Leaflet last updated on the eMC: 04/11/2008
PIL Amaryl

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/11/2008 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 10/09/2007 and displayed until 04/11/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 06/11/2006 and displayed until 10/09/2007
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 16/10/2002 and displayed until 06/11/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 22/04/2002 and displayed until 16/10/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 29/11/2000 and displayed until 22/04/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 08/08/2000 and displayed until 29/11/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   glimepiride


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk